Eisai shares sink after Japan regulators seek more data for review of Alzheimer’s drug
December 22, 2021 at 23:52 PM EST
Eisai Co. shares fell as much as 9.2% early Thursday morning after a Japanese government panel sought additional data for a review of the company's Aduhelm drug for Alzheimer's.
